Dysthymic Disorder

• 

  Subject Areas on Research

  • A comparison of pure and comorbid CD/ODD and depression. 
  • A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression. 
  • A fidelity measure for integrated management of depression in primary care. 
  • Adequacy of antidepressant treatment by psychiatric residents: the antidepressant treatment history form as a possible assessment tool. 
  • Bupropion and guanfacine. 
  • Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. 
  • Cognitive-behavioral therapy for suicide prevention (CBT-SP): treatment model, feasibility, and acceptability. 
  • Depressive morbidity and gender in community-dwelling Brazilian elderly: systematic review and meta-analysis. 
  • Depressive symptoms and clinical status during the Treatment of Adolescent Suicide Attempters (TASA) Study. 
  • Dimensions of social support and depression in patients at increased psychosocial risk recovering from myocardial infarction. 
  • Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: psychosocial outcomes. 
  • Hormone therapy does not affect depression severity in older women. 
  • Identifying depression in primary care: a literature synthesis of case-finding instruments. 
  • Improving primary care for depression in late life: the design of a multicenter randomized trial. 
  • Low yield of thyroid-stimulating hormone testing in elderly patients with depression. 
  • Patient beliefs predict response to paroxetine among primary care patients with dysthymia and minor depression. 
  • Predictors of nonresponse to treatment in primary care patients with dysthymia. 
  • Predictors of partial remission in older patients treated for major depression: the role of comorbid dysthymia. 
  • Prenatal dysthymia versus major depression effects on maternal cortisol and fetal growth. 
  • Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential. 
  • Sertraline versus imipramine to prevent relapse in chronic depression. 
  • Status of minor depression or dysthymia in primary care following a randomized controlled treatment. 
  • The 13- and 20-item Hopkins Symptom Checklist Depression Scale: psychometric properties in primary care patients with minor depression or dysthymia. 
  • The Treatment of Adolescent Suicide Attempters study (TASA): predictors of suicidal events in an open treatment trial. 
  • The course of depressive symptoms in older adults with comorbid major depression and dysthymia. 
  • The prevalence and severity of depressive symptoms along the spectrum of unipolar depressive disorders: a post hoc analysis. 
  • The relationship of aging and dysthymia in primary care. 
  • The role of readiness to change in response to treatment of adolescent depression. 
  • The treatment effectiveness project. A comparison of the effectiveness of paroxetine, problem-solving therapy, and placebo in the treatment of minor depression and dysthymia in primary care patients: background and research plan. 
  • The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapies. 
  • The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. 
  • The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. 
  • The undertreatment of dysthymia. 
  • Therapeutic reactance as a predictor of outcome in the treatment of chronic depression. 
  • Treatment of dysthymia and minor depression in primary care: A randomized controlled trial in older adults. 
  • Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years. 
  • Treatment of mild depression in elderly patients.